Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D07PTH
|
||||
Former ID |
DIB012605
|
||||
Drug Name |
13-cis-retinoic acid, UCSD
|
||||
Synonyms |
CRA, UCSD; 13-cis-retinoic acid
|
||||
Indication | Glioma [ICD9: 191; ICD10:C71] | Phase 3 | [525348] | ||
Company |
University of California San Diego
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
C1(=C(CCCC1(C)C)C)/C=C/C(=C/C=C/C(=C\C(=O)O)/C)/C
|
||||
Target and Pathway | |||||
Target(s) | Retinoic acid receptor | Target Info | Modulator | [525851], [551871] | |
References | |||||
Ref 525851 | 13-cis retinoic acid exerts its specific activity on human sebocytes through selective intracellular isomerization to all-trans retinoic acid and binding to retinoid acid receptors. J Invest Dermatol. 2000 Aug;115(2):321-7. | ||||
Ref 551871 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.